{"disease":{"id":"osteo-arthritis","name":"osteo arthritis"},"drugs":{"marketed":[{"drug_id":"prednisone","indication_name":"Post-traumatic osteoarthritis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Deltasone","generic_name":"prednisone","company_name":"Generic (originally Schering)","drug_phase":"marketed","molecular_target":"Annexin A1, Sodium/nucleoside cotransporter 1, Glucocorticoid receptor","drug_class":"Corticosteroid [EPC]","quality_score":40,"revenue":null,"mechanism":""},{"drug_id":"prednisone","indication_name":"Synovitis of osteoarthritis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Deltasone","generic_name":"prednisone","company_name":"Generic (originally Schering)","drug_phase":"marketed","molecular_target":"Annexin A1, Sodium/nucleoside cotransporter 1, Glucocorticoid receptor","drug_class":"Corticosteroid [EPC]","quality_score":40,"revenue":null,"mechanism":""},{"drug_id":"dexamethasone-phosphate","indication_name":"Post-traumatic osteoarthritis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Dexamethasone Sodium Phosphate","generic_name":"dexamethasone phosphate","company_name":"Merck & Co.","drug_phase":"marketed","molecular_target":"Androgen receptor, Glucocorticoid receptor, Mineralocorticoid receptor","drug_class":"Corticosteroid","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"dexamethasone-phosphate","indication_name":"Synovitis of osteoarthritis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Dexamethasone Sodium Phosphate","generic_name":"dexamethasone phosphate","company_name":"Merck & Co.","drug_phase":"marketed","molecular_target":"Androgen receptor, Glucocorticoid receptor, Mineralocorticoid receptor","drug_class":"Corticosteroid","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"nabumetone","indication_name":"Osteoarthritis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Relafen","generic_name":"NABUMETONE","company_name":"","drug_phase":"marketed","molecular_target":"Prostaglandin G/H synthase 1","drug_class":"Nonsteroidal Anti-inflammatory Drug [EPC]","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"meclofenamic-acid","indication_name":"Osteoarthritis Symptoms","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Meclofenamate","generic_name":"MECLOFENAMIC ACID","company_name":"","drug_phase":"marketed","molecular_target":"Prostaglandin G/H synthase 2","drug_class":"meclofenamic acid","quality_score":40,"revenue":null,"mechanism":""},{"drug_id":"fenoprofen-calcium","indication_name":"Osteoarthritis Symptoms","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"FENOPROFEN CALCIUM","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":35,"revenue":null,"mechanism":null},{"drug_id":"nsaids-ibubrofen-aspirin","indication_name":"Osteoarthritis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"NSAIDs \"ibubrofen,Aspirin\"","company_name":"Assiut University","drug_phase":"marketed","molecular_target":"","drug_class":"Nonsteroidal Anti-inflammatory Drug [EPC]","quality_score":20,"revenue":null,"mechanism":null},{"drug_id":"xzp-5610-tablet-for-part-c2","indication_name":"Osteoarthritis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"XZP-5610 Tablet for \"Part C2\"","company_name":"Xuanzhu Biopharmaceutical Co., Ltd.","drug_phase":"marketed","molecular_target":"","drug_class":"Nonsteroidal Anti-inflammatory Drug [EPC]","quality_score":15,"revenue":null,"mechanism":null},{"drug_id":"multiple-visit-corticosteroid-paste","indication_name":"Osteoarthritis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Multiple-Visit-\"Corticosteroid Paste\"","company_name":"Istanbul Medipol University Hospital","drug_phase":"marketed","molecular_target":"cyclooxygenase (COX-1 and COX-2)","drug_class":"Nonsteroidal Anti-inflammatory Drug [EPC]","quality_score":45,"revenue":null,"mechanism":"Naproxen reduces pain, inflammation, and fever by inhibiting prostaglandin synthesis through COX-1 and COX-2 inhibition."},{"drug_id":"isofezolac","indication_name":"Osteoarthritis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Sofenac","generic_name":"ISOFEZOLAC","company_name":"","drug_phase":"phase_2","molecular_target":"","drug_class":"isofezolac","quality_score":null,"revenue":null,"mechanism":"Sofenac works by inhibiting the COX-2 enzyme, which reduces inflammation and pain."},{"drug_id":"magnesium-salicylate","indication_name":"Osteoarthritis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Magan","generic_name":"magnesium salicylate","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"magnesium salicylate","quality_score":18,"revenue":null,"mechanism":""},{"drug_id":"celecoxib","indication_name":"Osteoarthritis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Celebrex","generic_name":"celecoxib","company_name":"Pfizer Inc. (originally Searle/Pharmacia)","drug_phase":"marketed","molecular_target":"COX-2","drug_class":"Nonsteroidal Anti-inflammatory Drug [EPC]","quality_score":10,"revenue":null,"mechanism":"Celecoxib works by inhibiting COX-2 to reduce prostaglandin synthesis, thereby decreasing pain, inflammation, and fever."},{"drug_id":"salsalate","indication_name":"Osteoarthritis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Sasapyrine","generic_name":"SALSALATE","company_name":"","drug_phase":"discontinued","molecular_target":"","drug_class":"salsalate","quality_score":null,"revenue":null,"mechanism":"Salsalate works by inhibiting the enzyme COX-1 and COX-2, which are responsible for producing prostaglandins."},{"drug_id":"dexibuprofen","indication_name":"Osteoarthritis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"DEXIBUPROFEN","company_name":"","drug_phase":"marketed","molecular_target":"Prostaglandin G/H synthase 1","drug_class":"dexibuprofen","quality_score":20,"revenue":null,"mechanism":""},{"drug_id":"choline-magnesium-trisalicylate","indication_name":"Osteoarthritis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Trilisate","generic_name":"CHOLINE MAGNESIUM TRISALICYLATE","company_name":"","drug_phase":"discontinued","molecular_target":"","drug_class":"choline magnesium trisalicylate","quality_score":null,"revenue":null,"mechanism":"Trilisate works by blocking the production of prostaglandins, hormone-like substances that cause pain and inflammation."},{"drug_id":"proglumetacin","indication_name":"Osteoarthritis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Afloxan","generic_name":"PROGLUMETACIN","company_name":"","drug_phase":"phase_2","molecular_target":"","drug_class":"proglumetacin","quality_score":24,"revenue":null,"mechanism":"Afloxan works by inhibiting the activity of enzymes called lipoxygenases, which play a role in the production of inflammatory mediators."},{"drug_id":"fenoprofen","indication_name":"Osteoarthritis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Nalfon","generic_name":"FENOPROFEN","company_name":"Pharmaco","drug_phase":"marketed","molecular_target":"Prostaglandin G/H synthase 1","drug_class":"Nonsteroidal Anti-inflammatory Drug","quality_score":55,"revenue":null,"mechanism":""},{"drug_id":"hydrocortisone-succinate","indication_name":"Post traumatic osteoarthritis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Solu-Cortef","generic_name":"hydrocortisone succinate","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Glucocorticoid receptor","drug_class":"Corticosteroid","quality_score":42,"revenue":null,"mechanism":""},{"drug_id":"hydrocortisone-succinate","indication_name":"Synovitis due to Osteoarthritis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Solu-Cortef","generic_name":"hydrocortisone succinate","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Glucocorticoid receptor","drug_class":"Corticosteroid","quality_score":42,"revenue":null,"mechanism":""},{"drug_id":"etofenamat","indication_name":"Osteoarthritis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Etofenamat","company_name":"Ankara City Hospital Bilkent","drug_phase":"phase_2","molecular_target":"","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"esflurbiprofen","indication_name":"Osteoarthritis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Loqoa","generic_name":"ESFLURBIPROFEN","company_name":"Taisho Pharmaceutical Co., Ltd.","drug_phase":"marketed","molecular_target":"Prostaglandin G/H synthase 2","drug_class":"","quality_score":17,"revenue":null,"mechanism":""},{"drug_id":"tramadol","indication_name":"Osteoarthritis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Ultram","generic_name":"tramadol","company_name":"Janssen","drug_phase":"marketed","molecular_target":"Solute carrier family 22 member 1, Delta-type opioid receptor, Kappa-type opioid receptor","drug_class":"","quality_score":40,"revenue":null,"mechanism":null},{"drug_id":"hydrocortisone-acetate","indication_name":"Post traumatic osteoarthritis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Cortifoam","generic_name":"HYDROCORTISONE ACETATE","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Corticosteroid-binding globulin","drug_class":"Corticosteroid","quality_score":42,"revenue":null,"mechanism":""},{"drug_id":"hydrocortisone-acetate","indication_name":"Synovitis due to Osteoarthritis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Cortifoam","generic_name":"HYDROCORTISONE ACETATE","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Corticosteroid-binding globulin","drug_class":"Corticosteroid","quality_score":42,"revenue":null,"mechanism":""},{"drug_id":"diclofenac","indication_name":"Osteoarthritis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Voltaren","generic_name":"DICLOFENAC","company_name":"Hisamitsu Pharmaceutical Co., Inc","drug_phase":"marketed","molecular_target":"Prostaglandin G/H synthase 2","drug_class":"Nonsteroidal Anti-inflammatory Drug","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"diclofenac","indication_name":"Osteoarthritis in Patients at High Ulcer Risk","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Voltaren","generic_name":"DICLOFENAC","company_name":"Hisamitsu Pharmaceutical Co., Inc","drug_phase":"marketed","molecular_target":"Prostaglandin G/H synthase 2","drug_class":"Nonsteroidal Anti-inflammatory Drug","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"cortisone-acetate","indication_name":"Post traumatic osteoarthritis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Cortone","generic_name":"CORTISONE ACETATE","company_name":"","drug_phase":"marketed","molecular_target":"Corticosteroid-binding globulin","drug_class":"alpha-Adrenergic Agonist [EPC]","quality_score":29,"revenue":null,"mechanism":""},{"drug_id":"cortisone-acetate","indication_name":"Synovitis due to Osteoarthritis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Cortone","generic_name":"CORTISONE ACETATE","company_name":"","drug_phase":"marketed","molecular_target":"Corticosteroid-binding globulin","drug_class":"alpha-Adrenergic Agonist [EPC]","quality_score":29,"revenue":null,"mechanism":""},{"drug_id":"betamethasone-acetate","indication_name":"Post traumatic osteoarthritis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Celestone Soluspan","generic_name":"BETAMETHASONE ACETATE","company_name":"","drug_phase":"marketed","molecular_target":"Glucocorticoid receptor","drug_class":"Corticosteroid","quality_score":42,"revenue":null,"mechanism":""},{"drug_id":"betamethasone-acetate","indication_name":"Synovitis due to Osteoarthritis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Celestone Soluspan","generic_name":"BETAMETHASONE ACETATE","company_name":"","drug_phase":"marketed","molecular_target":"Glucocorticoid receptor","drug_class":"Corticosteroid","quality_score":42,"revenue":null,"mechanism":""},{"drug_id":"dexamethasone","indication_name":"Synovitis due to Osteoarthritis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Decadron","generic_name":"dexamethasone","company_name":"Generic (originally Merck)","drug_phase":"marketed","molecular_target":"Annexin A1, Interleukin-4, Androgen receptor","drug_class":"Corticosteroid [EPC]","quality_score":44,"revenue":null,"mechanism":""},{"drug_id":"etofenamate","indication_name":"Osteoarthritis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Etofen","generic_name":"ETOFENAMATE","company_name":"","drug_phase":"phase_2","molecular_target":"","drug_class":"etofenamate","quality_score":null,"revenue":null,"mechanism":"Etofenamate works by blocking the production of prostaglandins, which are chemicals that cause pain and inflammation."},{"drug_id":"histamine","indication_name":"Osteoarthritis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Eramin","generic_name":"HISTAMINE","company_name":"Eli Lilly","drug_phase":"marketed","molecular_target":"Histamine H3 receptor","drug_class":"histamine","quality_score":44,"revenue":null,"mechanism":""},{"drug_id":"indom","indication_name":"Osteoarthritis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Indom","company_name":"University of Trieste","drug_phase":"marketed","molecular_target":"Aldo-keto reductase family 1 member C4, Dehydrogenase/reductase SDR family member 9, Nicotinate phosphoribosyltransferase","drug_class":"","quality_score":19,"revenue":null,"mechanism":null},{"drug_id":"lumiracoxib","indication_name":"Osteoarthritis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Joicela","generic_name":"LUMIRACOXIB","company_name":"Novartis Pharmaceuticals UK Limited","drug_phase":"marketed","molecular_target":"Prostaglandin G/H synthase 1","drug_class":"lumiracoxib","quality_score":24,"revenue":null,"mechanism":""},{"drug_id":"methylprednisolone","indication_name":"Post traumatic osteoarthritis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Medrol","generic_name":"methylprednisolone","company_name":"Generic (originally Upjohn/Pfizer)","drug_phase":"marketed","molecular_target":"Annexin A1, Short transient receptor potential channel 5, Glucocorticoid receptor","drug_class":"Glucocorticoid (corticosteroid)","quality_score":62,"revenue":null,"mechanism":"Potent synthetic glucocorticoid with 5x hydrocortisone potency and minimal mineralocorticoid activity, used for severe inflammatory conditions."},{"drug_id":"methylprednisolone","indication_name":"Synovitis due to Osteoarthritis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Medrol","generic_name":"methylprednisolone","company_name":"Generic (originally Upjohn/Pfizer)","drug_phase":"marketed","molecular_target":"Annexin A1, Short transient receptor potential channel 5, Glucocorticoid receptor","drug_class":"Glucocorticoid (corticosteroid)","quality_score":62,"revenue":null,"mechanism":"Potent synthetic glucocorticoid with 5x hydrocortisone potency and minimal mineralocorticoid activity, used for severe inflammatory conditions."},{"drug_id":"felbinac","indication_name":"Osteoarthritis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Traxam","generic_name":"FELBINAC","company_name":"","drug_phase":"phase_3","molecular_target":"Prostaglandin G/H synthase 1","drug_class":"felbinac","quality_score":null,"revenue":null,"mechanism":"Traxam works by blocking the production of prostaglandins, hormone-like substances that cause pain and inflammation."},{"drug_id":"esomeprazole","indication_name":"Osteoarthritis in Patients at High Ulcer Risk","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Nexium","generic_name":"esomeprazole","company_name":"AstraZeneca","drug_phase":"marketed","molecular_target":"Potassium-transporting ATPase","drug_class":"Proton pump inhibitor (PPI)","quality_score":24,"revenue":null,"mechanism":""},{"drug_id":"polmacoxib","indication_name":"Osteoarthritis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Acelex","generic_name":"POLMACOXIB","company_name":"CrystalGenomics","drug_phase":"marketed","molecular_target":"Prostaglandin G/H synthase 2","drug_class":"","quality_score":17,"revenue":null,"mechanism":""},{"drug_id":"hydrocortisone","indication_name":"Post traumatic osteoarthritis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Cortef","generic_name":"hydrocortisone","company_name":"Generic (originally Merck/Upjohn)","drug_phase":"marketed","molecular_target":"Annexin A1, Corticosteroid-binding globulin, Nitric oxide synthase, inducible","drug_class":"Corticosteroid [EPC]","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"hydrocortisone","indication_name":"Synovitis due to Osteoarthritis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Cortef","generic_name":"hydrocortisone","company_name":"Generic (originally Merck/Upjohn)","drug_phase":"marketed","molecular_target":"Annexin A1, Corticosteroid-binding globulin, Nitric oxide synthase, inducible","drug_class":"Corticosteroid [EPC]","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"azapropazone","indication_name":"Osteoarthritis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Apazone","generic_name":"azapropazone","company_name":"","drug_phase":"marketed","molecular_target":"Prostaglandin G/H synthase 1","drug_class":"azapropazone","quality_score":27,"revenue":null,"mechanism":""},{"drug_id":"aceclofenac","indication_name":"Osteoarthritis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Hifenac","generic_name":"ACECLOFENAC","company_name":"","drug_phase":"marketed","molecular_target":"Transthyretin","drug_class":"aceclofenac","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"triamcinolone","indication_name":"Post traumatic osteoarthritis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Rodinolone","generic_name":"TRIAMCINOLONE","company_name":"","drug_phase":"marketed","molecular_target":"Glucocorticoid receptor","drug_class":"Corticosteroid","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"triamcinolone","indication_name":"Synovitis due to Osteoarthritis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Rodinolone","generic_name":"TRIAMCINOLONE","company_name":"","drug_phase":"marketed","molecular_target":"Glucocorticoid receptor","drug_class":"Corticosteroid","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"diclofenac-etalhyaluronate-sodium","indication_name":"Osteoarthritis of hip","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Joycle","generic_name":"diclofenac etalhyaluronate sodium","company_name":"Seikagaku Corporation","drug_phase":"marketed","molecular_target":"Prostaglandin E2 receptor EP2 subtype","drug_class":"","quality_score":17,"revenue":null,"mechanism":""},{"drug_id":"diclofenac-etalhyaluronate-sodium","indication_name":"Osteoarthritis of knee","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Joycle","generic_name":"diclofenac etalhyaluronate sodium","company_name":"Seikagaku Corporation","drug_phase":"marketed","molecular_target":"Prostaglandin E2 receptor EP2 subtype","drug_class":"","quality_score":17,"revenue":null,"mechanism":""},{"drug_id":"lithium","indication_name":"Osteoarthritis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Lithobid","generic_name":"lithium carbonate","company_name":"Generic (multiple manufacturers)","drug_phase":"marketed","molecular_target":"Inositol-1(or 4)-monophosphatase 1, Glycogen synthase kinase-3","drug_class":"Mood stabilizer","quality_score":45,"revenue":null,"mechanism":""},{"drug_id":"ibuprofen","indication_name":"Osteoarthritis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Advil","generic_name":"ibuprofen","company_name":"Generic (originally Boots Group)","drug_phase":"marketed","molecular_target":"Sodium-coupled monocarboxylate transporter 1, Acid-sensing ion channel 1, Aldo-keto reductase family 1 member C2","drug_class":"Nonsteroidal Anti-inflammatory Drug [EPC]","quality_score":40,"revenue":null,"mechanism":"Ibuprofen inhibits prostaglandin synthetase, reducing pain, fever, and inflammation."},{"drug_id":"acetylsalicylic-acid","indication_name":"Osteoarthritis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Norgesic","generic_name":"acetylsalicylic acid","company_name":"Endo","drug_phase":"marketed","molecular_target":"reticular formation (brain stem)","drug_class":"centrally acting muscle relaxant with anticholinergic properties","quality_score":82,"revenue":null,"mechanism":"Orphenadrine citrate centrally acts on brain stem to selectively block facilitatory reticular functions."},{"drug_id":"indomethacin","indication_name":"Osteoarthritis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Indocin Sr","generic_name":"INDOMETHACIN","company_name":"","drug_phase":"marketed","molecular_target":"Prostaglandin E2 receptor EP2 subtype","drug_class":"Nonsteroidal Anti-inflammatory Drug [EPC]","quality_score":80,"revenue":null,"mechanism":"Indomethacin works by blocking the production of prostaglandins, which are hormone-like substances that cause pain and inflammation."},{"drug_id":"imrecoxib","indication_name":"Osteoarthritis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"IMRECOXIB","company_name":"HengRui","drug_phase":"marketed","molecular_target":"Prostaglandin G/H synthase 2","drug_class":"","quality_score":30,"revenue":null,"mechanism":""},{"drug_id":"lithium-carbonate","indication_name":"Osteoarthritis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Lithium Carbonate","generic_name":"LITHIUM CARBONATE","company_name":"","drug_phase":"marketed","molecular_target":"Glycogen synthase kinase-3","drug_class":"lithium carbonate","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"cytotec","indication_name":"Osteoarthritis in Patients at High Ulcer Risk","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Cytotec","generic_name":"Misoprostol","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Cyclooxygenase (COX-1 and COX-2); Prostaglandin receptors","drug_class":"NSAID combined with prostaglandin analog","quality_score":70,"revenue":null,"mechanism":"Diclofenac inhibits COX-1/COX-2 to reduce prostaglandins; misoprostol is PGE1 analog protecting gastric mucosa."},{"drug_id":"diflunisal","indication_name":"Osteoarthritis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Dolobid","generic_name":"DIFLUNISAL","company_name":"","drug_phase":"marketed","molecular_target":"Prostaglandin G/H synthase 2","drug_class":"Nonsteroidal Anti-inflammatory Drug [EPC]","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"piroxicam","indication_name":"Osteoarthritis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Feldene","generic_name":"PIROXICAM","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Prostaglandin G/H synthase 1","drug_class":"Nonsteroidal Anti-inflammatory Drug [EPC]","quality_score":70,"revenue":null,"mechanism":"Feldene works by blocking the production of prostaglandins, hormone-like substances that cause pain and inflammation."},{"drug_id":"daypro","indication_name":"Osteoarthritis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Daypro","generic_name":"Oxaprozin","company_name":"Solubiomix","drug_phase":"marketed","molecular_target":"Prostaglandin G/H synthase 1","drug_class":"Nonsteroidal Anti-inflammatory Drug [EPC]","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"ketoprofen","indication_name":"Osteoarthritis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Orudis","generic_name":"KETOPROFEN","company_name":"","drug_phase":"marketed","molecular_target":"Prostaglandin G/H synthase 1","drug_class":"Nonsteroidal Anti-inflammatory Drug [EPC]","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"etodolac","indication_name":"Osteoarthritis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Lodine","generic_name":"ETODOLAC","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Prostaglandin G/H synthase 2","drug_class":"Nonsteroidal Anti-inflammatory Drug [EPC]","quality_score":55,"revenue":null,"mechanism":""},{"drug_id":"arthrotec","indication_name":"Osteoarthritis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Arthrotec","generic_name":"Diclofenac Sodium","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Acid-sensing ion channel 3","drug_class":"diclofenac","quality_score":65,"revenue":null,"mechanism":""},{"drug_id":"arthrotec","indication_name":"Osteoarthritis in Patients at High Ulcer Risk","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Arthrotec","generic_name":"Diclofenac Sodium","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Acid-sensing ion channel 3","drug_class":"diclofenac","quality_score":65,"revenue":null,"mechanism":""},{"drug_id":"nabumetone","indication_name":"Osteoarthritis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Relafen","generic_name":"NABUMETONE","company_name":"","drug_phase":"marketed","molecular_target":"Prostaglandin G/H synthase 1","drug_class":"Nonsteroidal Anti-inflammatory Drug [EPC]","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"intra-articular-corticosteroid-injections","indication_name":"Osteoarthritis of the knee","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Intra-articular corticosteroid injections","generic_name":"intra-articular-corticosteroid-injections","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Glucocorticoid receptor","drug_class":"Corticosteroid","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"intra-articular-corticosteroid-injections","indication_name":"Osteoarthritis of the hip","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Intra-articular corticosteroid injections","generic_name":"intra-articular-corticosteroid-injections","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Glucocorticoid receptor","drug_class":"Corticosteroid","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"meclofenamic-acid","indication_name":"Osteoarthritis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Meclofenamate","generic_name":"MECLOFENAMIC ACID","company_name":"","drug_phase":"marketed","molecular_target":"Prostaglandin G/H synthase 2","drug_class":"meclofenamic acid","quality_score":40,"revenue":null,"mechanism":""},{"drug_id":"tolmetin","indication_name":"Osteoarthritis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Tolectin 600","generic_name":"TOLMETIN","company_name":"","drug_phase":"marketed","molecular_target":"Prostaglandin G/H synthase 2","drug_class":"Nonsteroidal Anti-inflammatory Drug","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"betamethasone","indication_name":"Post traumatic osteoarthritis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Betametasone","generic_name":"BETAMETHASONE","company_name":"","drug_phase":"marketed","molecular_target":"Glucocorticoid receptor","drug_class":"Corticosteroid","quality_score":65,"revenue":null,"mechanism":"Betamethasone works by binding to the glucocorticoid receptor, which then triggers a series of downstream effects that reduce inflammation and suppress the immune system."},{"drug_id":"betamethasone","indication_name":"Synovitis due to Osteoarthritis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Betametasone","generic_name":"BETAMETHASONE","company_name":"","drug_phase":"marketed","molecular_target":"Glucocorticoid receptor","drug_class":"Corticosteroid","quality_score":65,"revenue":null,"mechanism":"Betamethasone works by binding to the glucocorticoid receptor, which then triggers a series of downstream effects that reduce inflammation and suppress the immune system."},{"drug_id":"meloxicam","indication_name":"Osteoarthritis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Mobic","generic_name":"MELOXICAM","company_name":"Boehringer Ingelheim","drug_phase":"marketed","molecular_target":"Prostaglandin G/H synthase 2","drug_class":"Nonsteroidal Anti-inflammatory Drug [EPC]","quality_score":10,"revenue":null,"mechanism":"Meloxicam works by inhibiting the enzyme prostaglandin G/H synthase 2, which is involved in the production of prostaglandins that cause pain and inflammation."},{"drug_id":"flurbiprofen","indication_name":"Osteoarthritis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Ocufen","generic_name":"flurbiprofen","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Prostaglandin G/H synthase 1","drug_class":"Nonsteroidal Anti-inflammatory Drug","quality_score":65,"revenue":null,"mechanism":""},{"drug_id":"misoprostol","indication_name":"Osteoarthritis in Patients at High Ulcer Risk","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Cytotec","generic_name":"misoprostol","company_name":"Generic (originally Searle/Pfizer)","drug_phase":"marketed","molecular_target":"Prostaglandin E2 receptor EP2 subtype, Prostaglandin E2 receptor EP3 subtype, Prostaglandin E2 receptor EP4 subtype","drug_class":"Prostaglandin E1 analog","quality_score":null,"revenue":null,"mechanism":"Synthetic prostaglandin E1 analog that protects gastric mucosa by inhibiting acid secretion and stimulating mucus/bicarbonate, also causes uterine contraction."},{"drug_id":"cortisol","indication_name":"Post traumatic osteoarthritis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Cortisol","company_name":"University of Zurich","drug_phase":"marketed","molecular_target":"Annexin A1, Corticosteroid-binding globulin, Nitric oxide synthase, inducible","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"cortisol","indication_name":"Synovitis due to Osteoarthritis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Cortisol","company_name":"University of Zurich","drug_phase":"marketed","molecular_target":"Annexin A1, Corticosteroid-binding globulin, Nitric oxide synthase, inducible","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"prednisolone","indication_name":"Post traumatic osteoarthritis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Prelone","generic_name":"prednisolone","company_name":"Generic (originally Schering)","drug_phase":"marketed","molecular_target":"Annexin A1, Corticosteroid-binding globulin, G-protein coupled bile acid receptor 1","drug_class":"Glucocorticoid (corticosteroid)","quality_score":40,"revenue":null,"mechanism":""},{"drug_id":"prednisolone","indication_name":"Synovitis due to Osteoarthritis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Prelone","generic_name":"prednisolone","company_name":"Generic (originally Schering)","drug_phase":"marketed","molecular_target":"Annexin A1, Corticosteroid-binding globulin, G-protein coupled bile acid receptor 1","drug_class":"Glucocorticoid (corticosteroid)","quality_score":40,"revenue":null,"mechanism":""},{"drug_id":"celebrex","indication_name":"Osteoarthritis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"celebrex","company_name":"POZEN","drug_phase":"marketed","molecular_target":"3-phosphoinositide-dependent protein kinase 1, Adenosine receptor A3, Cytochrome c oxidase subunit 2","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"prednisolon","indication_name":"Post traumatic osteoarthritis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"prednisolon","company_name":"Hannover Medical School","drug_phase":"marketed","molecular_target":"Annexin A1, Corticosteroid-binding globulin, G-protein coupled bile acid receptor 1","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"prednisolon","indication_name":"Synovitis due to Osteoarthritis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"prednisolon","company_name":"Hannover Medical School","drug_phase":"marketed","molecular_target":"Annexin A1, Corticosteroid-binding globulin, G-protein coupled bile acid receptor 1","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"vioxx","indication_name":"Osteoarthritis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Vioxx","company_name":"M.D. Anderson Cancer Center","drug_phase":"discontinued","molecular_target":"Cytochrome c oxidase subunit 2, Prostaglandin E2 receptor EP2 subtype, Prostaglandin G/H synthase 1","drug_class":"","quality_score":null,"revenue":null,"mechanism":""},{"drug_id":"methylprednisolon","indication_name":"Post traumatic osteoarthritis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Methylprednisolon","company_name":"Leiden University Medical Center","drug_phase":"marketed","molecular_target":"Annexin A1, Short transient receptor potential channel 5, Glucocorticoid receptor","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"methylprednisolon","indication_name":"Synovitis due to Osteoarthritis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Methylprednisolon","company_name":"Leiden University Medical Center","drug_phase":"marketed","molecular_target":"Annexin A1, Short transient receptor potential channel 5, Glucocorticoid receptor","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"indometacin","indication_name":"Osteoarthritis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"indometacin","company_name":"Maastricht University Medical Center","drug_phase":"marketed","molecular_target":"Aldo-keto reductase family 1 member C4, Dehydrogenase/reductase SDR family member 9, Nicotinate phosphoribosyltransferase","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"meclofenamate","indication_name":"Osteoarthritis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Meclofenamate","company_name":"Memorial Sloan Kettering Cancer Center","drug_phase":"marketed","molecular_target":"Aldo-keto reductase family 1 member C1, Aldo-keto reductase family 1 member C2, Aldo-keto reductase family 1 member C3","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"naproxen","indication_name":"Osteoarthritis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Aleve","generic_name":"naproxen","company_name":"Generic (originally Syntex)","drug_phase":"marketed","molecular_target":"Aldo-keto reductase family 1 member C2, Aldo-keto reductase family 1 member C3, Prostaglandin G/H synthase 1","drug_class":"NSAID","quality_score":null,"revenue":null,"mechanism":"Reversibly inhibits COX-1 and COX-2 with a long half-life, providing sustained anti-inflammatory, analgesic, and antipyretic effects."}],"pipeline":[],"offLabel":[],"totalMarketed":86,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03573765","title":"Epidemiology and Outcomes of Upper Limb Surgery: Analysis of Routine Data","phase":"","overall_status":"COMPLETED","enrollment_count":8308821,"lead_sponsor_name":"University of Oxford","has_results":false},{"nct_id":"NCT05813652","title":"Relative Impacts on Preventative Primary Care--a Longitudinal Evaluation of COVID-19:Phase 1","phase":"","overall_status":"COMPLETED","enrollment_count":919928,"lead_sponsor_name":"McMaster University","has_results":false},{"nct_id":"NCT01685424","title":"Etoricoxib Prescribing Patterns and Adverse Events of Interest in Primary Care in the United Kingdom (MK-0663-162 AM1)","phase":"","overall_status":"COMPLETED","enrollment_count":79189,"lead_sponsor_name":"Organon and Co","has_results":false},{"nct_id":"NCT05105646","title":"Are Perception of Pain and Psychological Distress Before Knee Arthroplasty Associated With Reason for Revision?","phase":"","overall_status":"COMPLETED","enrollment_count":70754,"lead_sponsor_name":"Leiden University Medical Center","has_results":false},{"nct_id":"NCT06148779","title":"Can Digitally Delivered First-line Osteoarthritis Treatment Improve Equal Access to Care","phase":"","overall_status":"RECRUITING","enrollment_count":50000,"lead_sponsor_name":"Joint Academy","has_results":false},{"nct_id":"NCT03350568","title":"Dietary Antioxidants and Chronic Diseases-The Swedish National March Cohort","phase":"","overall_status":"COMPLETED","enrollment_count":43880,"lead_sponsor_name":"Karolinska Institutet","has_results":false},{"nct_id":"NCT03840928","title":"PatientSpot Formerly Known as ArthritisPower","phase":"","overall_status":"UNKNOWN","enrollment_count":40000,"lead_sponsor_name":"Global Healthy Living Foundation","has_results":false},{"nct_id":"NCT05603728","title":"Exactech Shoulder Post Market Clinical Follow-up Study","phase":"","overall_status":"RECRUITING","enrollment_count":20000,"lead_sponsor_name":"Exactech","has_results":false},{"nct_id":"NCT05530551","title":"Effect of Single vs Multiple Prophylactic Antibiotic Doses on PJI Following Primary THA in Patients With OA","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":20000,"lead_sponsor_name":"Soren Overgaard","has_results":false},{"nct_id":"NCT05455177","title":"Change in Patient Reported Outcomes and Wish for Joint Surgery","phase":"","overall_status":"COMPLETED","enrollment_count":14018,"lead_sponsor_name":"Joint Academy","has_results":false},{"nct_id":"NCT04203732","title":"Evaluation of Anesthetic Techniques in Outpatient Total Joint Replacement Surgery in an Integrated Health Care Delivery System","phase":"","overall_status":"COMPLETED","enrollment_count":12466,"lead_sponsor_name":"Kaiser Permanente","has_results":false},{"nct_id":"NCT06010979","title":"Clinical Cohort Study of Knee Arthroplasty Assisted by Digital Technology","phase":"","overall_status":"RECRUITING","enrollment_count":12000,"lead_sponsor_name":"Tian Hua","has_results":false},{"nct_id":"NCT05316194","title":"Minimal Clinically Important Changes in Osteoarthritis Treatment","phase":"","overall_status":"COMPLETED","enrollment_count":11708,"lead_sponsor_name":"Joint Academy","has_results":false},{"nct_id":"NCT06687109","title":"A Prospective Total Joint Surgery Registry to Monitor Short- and Long-Term Clinical Outcomes","phase":"","overall_status":"RECRUITING","enrollment_count":10000,"lead_sponsor_name":"Spokane Joint Replacement Center","has_results":false},{"nct_id":"NCT03711773","title":"Outcomes of Low-Impact Exercise Program for People With Ankle, Knee, and/or Hip Pain","phase":"NA","overall_status":"RECRUITING","enrollment_count":10000,"lead_sponsor_name":"University of Missouri-Columbia","has_results":false},{"nct_id":"NCT05495334","title":"Innovations in Genicular Outcomes Registry","phase":"","overall_status":"RECRUITING","enrollment_count":10000,"lead_sponsor_name":"Pacira Pharmaceuticals, Inc","has_results":false},{"nct_id":"NCT07231471","title":"Platelet Rich Plasma for Musculoskeletal Conditions","phase":"NA","overall_status":"RECRUITING","enrollment_count":10000,"lead_sponsor_name":"University of Utah","has_results":false},{"nct_id":"NCT03472300","title":"Prevalence of Self-disclosed Knee Trouble and Use of Treatments Among Elderly Individuals","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":9600,"lead_sponsor_name":"Frederiksberg University Hospital","has_results":false},{"nct_id":"NCT04135170","title":"Antibiotic Loaded Bone Cement in Prevention of Periprosthetic Joint Infections in Primary Total Knee Arthroplasty","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":9172,"lead_sponsor_name":"The Norwegian Arthroplasty Register","has_results":false},{"nct_id":"NCT00261066","title":"Outcome Following Orthopaedic Surgery","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":8439,"lead_sponsor_name":"Ottawa Hospital Research Institute","has_results":false},{"nct_id":"NCT03632122","title":"Subgroups of Older Adults With Back Pain and Multiple Chronic Conditions","phase":"","overall_status":"COMPLETED","enrollment_count":8344,"lead_sponsor_name":"University of Washington","has_results":false},{"nct_id":"NCT05543941","title":"Evaluating XPERIENCE™ Advanced Surgical Irrigation","phase":"NA","overall_status":"RECRUITING","enrollment_count":7600,"lead_sponsor_name":"Ottawa Hospital Research Institute","has_results":false},{"nct_id":"NCT04836988","title":"Face to Face or Digitally Delivered First-line Osteoarthritis Treatment?","phase":"","overall_status":"COMPLETED","enrollment_count":6946,"lead_sponsor_name":"Lund University","has_results":false},{"nct_id":"NCT03737149","title":"A Prospective Multicenter Longitudinal Cohort Study of the Mymobility Platform","phase":"NA","overall_status":"COMPLETED","enrollment_count":6559,"lead_sponsor_name":"Zimmer Biomet","has_results":true},{"nct_id":"NCT00092703","title":"Investigational Drug Versus an Approved Drug in Patients With Osteoarthritis (0663-061)(COMPLETED)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":6000,"lead_sponsor_name":"Organon and Co","has_results":false},{"nct_id":"NCT04960098","title":"Patient-reported Outcome Measures in Patient Underwent Total Hip and Knee Arthroplasty","phase":"","overall_status":"RECRUITING","enrollment_count":5816,"lead_sponsor_name":"I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio","has_results":false},{"nct_id":"NCT03102580","title":"Development of an Osteoarthritis (OA) Care Plan to Improve Process and Quality of OA Treatment Decisions","phase":"NA","overall_status":"COMPLETED","enrollment_count":5713,"lead_sponsor_name":"University of Massachusetts, Worcester","has_results":true},{"nct_id":"NCT02683239","title":"Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":5331,"lead_sponsor_name":"Regeneron Pharmaceuticals","has_results":true},{"nct_id":"NCT04375280","title":"Evaluation of Impaired Mobility in Chronic Illness Constitution of a Cohort","phase":"NA","overall_status":"RECRUITING","enrollment_count":5000,"lead_sponsor_name":"University Hospital, Clermont-Ferrand","has_results":false},{"nct_id":"NCT03746184","title":"The Right Treatment for the Right Patient At the Right Time. a Study Following 5,000 Patients with Knee Osteoarthritis","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":5000,"lead_sponsor_name":"Hvidovre University Hospital","has_results":false},{"nct_id":"NCT07006701","title":"A Population-based Cohort of Osteoarthritis: the Tsinghua University Tiantongyuan Community Osteoarthritis Study","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":4000,"lead_sponsor_name":"Beijing Tsinghua Chang Gung Hospital","has_results":false},{"nct_id":"NCT05527860","title":"Evolution of the State of Health of Patients Undergoing Surgery for Osteoarticular Surgery","phase":"","overall_status":"UNKNOWN","enrollment_count":4000,"lead_sponsor_name":"University Hospital, Strasbourg, France","has_results":false},{"nct_id":"NCT04437134","title":"On-line Neuromuscular Exercise and Education for Knee Osteoarthritis","phase":"","overall_status":"COMPLETED","enrollment_count":3789,"lead_sponsor_name":"Slagelse Hospital","has_results":false},{"nct_id":"NCT03161093","title":"A Study to Determine the Safety and the Efficacy of Fasinumab Compared to Placebo and Naproxen for Treatment of Adults With Pain From Osteoarthritis of the Knee or Hip","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":3307,"lead_sponsor_name":"Regeneron Pharmaceuticals","has_results":true},{"nct_id":"NCT04490798","title":"Effectiveness of Acupuncture Clinical Pathway","phase":"","overall_status":"COMPLETED","enrollment_count":3245,"lead_sponsor_name":"Hospital Son Llatzer","has_results":false},{"nct_id":"NCT02528188","title":"Long Term Safety and Efficacy Study of Tanezumab in Subjects With Osteoarthritis of the Hip or Knee","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":3021,"lead_sponsor_name":"Pfizer","has_results":true},{"nct_id":"NCT03192787","title":"A Registry Study of Sanwujiaowan Capsule Used in Clinical Real World","phase":"","overall_status":"UNKNOWN","enrollment_count":3000,"lead_sponsor_name":"Yanming Xie","has_results":false},{"nct_id":"NCT01953523","title":"Safety and Clinical Outcomes Study: SVF Deployment for Orthopedic, Neurologic, Urologic, and Cardio-pulmonary Conditions","phase":"NA","overall_status":"COMPLETED","enrollment_count":3000,"lead_sponsor_name":"Elliot Lander","has_results":false},{"nct_id":"NCT06583395","title":"Quest to Analyze One Thousand Humans Meditating","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":3000,"lead_sponsor_name":"Tobias Moeller-Bertram","has_results":false},{"nct_id":"NCT03412864","title":"A Post Marketing Surveillance Study of INVOSSA K Inj.","phase":"","overall_status":"UNKNOWN","enrollment_count":3000,"lead_sponsor_name":"Kolon Life Science","has_results":false},{"nct_id":"NCT00809354","title":"Long-Term Analgesic Efficacy And Safety Of Tanezumab Alone Or In Combination With Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Versus NSAIDs Alone In Patients With Osteoarthritis Of The Knee Or Hip","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":2720,"lead_sponsor_name":"Pfizer","has_results":true},{"nct_id":"NCT06747494","title":"General vs Spinal in Total Joint Arthroplasty (TJA)","phase":"NA","overall_status":"RECRUITING","enrollment_count":2396,"lead_sponsor_name":"University of Miami","has_results":false},{"nct_id":"NCT05661760","title":"Predicting Successful Outcome of Interdisciplinary Biopsychosocial Rehabilitation in Osteoarthritis","phase":"","overall_status":"UNKNOWN","enrollment_count":2309,"lead_sponsor_name":"Maastricht University","has_results":false},{"nct_id":"NCT00809783","title":"Extension Study Of Tanezumab In Osteoarthritis","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":2147,"lead_sponsor_name":"Pfizer","has_results":true},{"nct_id":"NCT04075526","title":"Vancomycin Powder and Dilute Povidone Iodine Lavage for Infection Prophylaxis in High Risk Total Joint Arthroplasty","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":2129,"lead_sponsor_name":"NYU Langone Health","has_results":true},{"nct_id":"NCT04846010","title":"Recovering Damaged Cells for Sequelae Caused by COVID-19, SARS-CoV-2","phase":"PHASE1, PHASE2","overall_status":"UNKNOWN","enrollment_count":2000,"lead_sponsor_name":"All Natural Medicine Clinic, LLC","has_results":false},{"nct_id":"NCT06249958","title":"Transforming Rehabilitation: Personalised Care for a Better Quality of Life","phase":"","overall_status":"RECRUITING","enrollment_count":2000,"lead_sponsor_name":"I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio","has_results":false},{"nct_id":"NCT03309501","title":"Tong-Luo-Qu-Tong Plaster for KOA: a Randomised, Double-blind, Parallel Positive Control, Multi-center Clinical Trial","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":2000,"lead_sponsor_name":"Shanghai University of Traditional Chinese Medicine","has_results":false},{"nct_id":"NCT04369261","title":"Observational Study of Synovian® Inj. in Patients With Osteoarthritis in the Knee","phase":"","overall_status":"COMPLETED","enrollment_count":1949,"lead_sponsor_name":"LG Chem","has_results":false},{"nct_id":"NCT04504812","title":"A Sequenced Strategy for Improving Outcomes in People With Knee Osteoarthritis Pain","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1937,"lead_sponsor_name":"Johns Hopkins University","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}